Continued Improvement of Signs and Symptoms in Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study.

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
McInnes, Iain B. [2 ]
Gottlieb, Alice B. [3 ]
Puig, Lluis [4 ]
Rahman, Proton [5 ]
Ritchlin, Christopher T. [6 ]
Li, Shu [7 ]
Wang, Yuhua [7 ]
Doyle, Mittie K. [7 ]
Mendelsohn, Alan M. [7 ]
机构：
[1] UCSD Sch Med, La Jolla, CA USA
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Tufts Med Ctr, Boston, MA USA
[4] Univ Autonoma Barcelona, Barcelona, Spain
[5] Mem Univ Newfoundland, St John, NF, Canada
[6] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[7] Janssen Res & Dev LLC, Spring House, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
L4
引用
收藏
页码：4168 / 4168
页数：1
相关论文
共 50 条
  • [1] CONTINUED IMPROVEMENT OF SIGNS AND SYMPTOMS IN USTEKINUMAB-TREATED PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: WEEK 52 RESULTS OF A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Kavanaugh, A.
    McInnes, I. B.
    Gottlieb, A. B.
    Puig, L.
    Rahman, P.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Doyle, M.
    Mendelsohn, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 674 - 675
  • [2] Continued improvement of signs and symptoms in ustekinumab-treated patients with active psoriatic arthritis: week 52 results of a phase 3, multicenter, double-blind, placebo-controlled study
    Puig, L.
    Kavanaugh, A.
    McInnes, I. B.
    Gottlieb, A. B.
    Rahman, P.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Doyle, M. K.
    Mendelsohn, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 53 - 53
  • [3] Ustekinumab in Patients with Active Psoriatic Arthritis: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Psummit I Study
    Kavanaugh, Arthur
    McInnes, Iain B.
    Gottlieb, Alice B.
    Puig, Lluis
    Rahman, Proton
    Ritchlin, Christopher T.
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Doyle, Mittie K.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1083 - S1084
  • [4] Ustekinumab in Patients with Active Psoriatic Arthritis: Results of the Phase 3, Multicenter, Double-blind, Placebo-Controlled PSUMMIT I Study
    Rahman, Proton
    Kavanaugh, Arthur
    Gottlieb, Alice
    Puig, Lluis
    Ritchlin, Christopher
    McInnes, Iain
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Doyle, Mittie
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 983 - 983
  • [5] USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF THE PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PSUMMIT I STUDY
    McInnes, I. B.
    Kavanaugh, A.
    Gottlieb, A. B.
    Puig, L.
    Rahman, P.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Doyle, M. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 107 - 107
  • [6] Ustekinumab in patients with active psoriatic arthritis: Results of the phase III, multicenter, double-blind, placebo-controlled PSUMMIT I study
    Gottlieb, Alice
    Kavanaugh, Arthur
    McInnes, Iain
    Puig, Lluis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB218 - AB218
  • [7] Vunakizumab in Patients with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study
    Zou, Hejian
    Wan, Weiguo
    Xue, Yu
    Sun, Lingyun
    Zhang, Ning
    Chen, Haiying
    Shi, Xiaofei
    Liu, Shengyun
    Chen, Lin
    Ma, Xinmei
    Wei, Hua
    Jiang, Zhenyu
    Li, Xiaomei
    Fan, Hongtao
    Li, Hongbin
    Li, Jingyang
    Wu, Rui
    Shi, Guixiu
    Zhu, Jing
    Kong, Xiaodan
    Lu, Yuewu
    Cui, Xiaojing
    Zheng, Qianning
    Bai, Xiaoyan
    Dong, Guangchao
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5240 - 5242
  • [8] Efficacy of ixekizumab in patients with psoriatic arthritis: Results of a phase 3 randomized, double-blind, active- and placebo-controlled study
    Mease, Philip
    van der Heijde, Desiree
    Ritchlin, Christopher
    Cuchacovich, Rachel
    Shuler, Catherine
    Lin, Chen-Yen
    Vangerow, Harald
    Samanta, Suvajit
    Lee, Chin
    Gladman, Dafna
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB248 - AB248
  • [9] Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study
    Schett, Georg
    Wollenhaupt, Jurgen
    Papp, Kim
    Joos, Rik
    Rodrigues, Jude F.
    Vessey, Adele R.
    Hu, ChiaChi
    Stevens, Randall
    de Vlam, Kurt L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : 3156 - 3167
  • [10] Secukinumab improves signs and symptoms of active psoriatic arthritis: Results from a phase 3 randomized, multicenter, double-blind, placebo-controlled study using a subcutaneous dosing regimen (FUTURE 2)
    Gottlieb, A. B.
    McInnes, I. B.
    Mease, P.
    Kirkham, B.
    Kavanaugh, A.
    Ligozio, G.
    Pricop, L.
    Mpofu, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S29 - S29
12345